Related Experiment Video
Updated: Apr 17, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
A statistical model to predict one-year risk of death in patients with cystic fibrosis
Shawn D Aaron1, Anne L Stephenson2, Donald W Cameron1
1Division Head of Respiratory Medicine, Ottawa Hospital Research Institute, University of Ottawa, The Ottawa Hospital, 501 Smyth Road, Ottawa, Ontario, K1H 8L6 Canada.
Insights
A new statistical model accurately predicts the 1-year risk of death for cystic fibrosis (CF) patients. This tool helps clinicians assess patient survival and optimize lung transplant referrals.
Area of Science:
- Medical Statistics
- Pulmonology
- Genetics
Background:
- Cystic Fibrosis (CF) is a chronic genetic disease requiring continuous monitoring.
- Assessing mortality risk between clinical visits is crucial for timely interventions.
Purpose of the Study:
- To develop a statistical model for predicting the 1-year risk of death in CF patients.
- To create a clinical scoring tool integrating chronic health and exacerbation risks.
Main Methods:
- Utilized Canadian CF registry data (3,794 patients, 44,390 visits).
- Employed a stochastic process model with threshold regression for survival analysis.
- Identified key clinical covariates influencing CF health and exacerbations.
Main Results:
- Significant factors for chronic health included lung function, P. aeruginosa infection, and CF-related diabetes.
- Exacerbation risk was associated with lung function decline, age, and prior hospitalizations.
- The integrated model demonstrated excellent predictive validity for 1-year mortality.
Conclusions:
- A novel threshold regression model accurately predicts 1-year survival in CF patients.
- The developed clinical scoring tool aids in assessing individual patient risk.
- This tool can inform decisions regarding lung transplant referrals.
Objectives:
We constructed a statistical model to assess the risk of death for cystic fibrosis (CF) patients between scheduled annual clinical visits. Our model includes a CF health index that shows the influence of risk factors on CF chronic health and on the severity and frequency of CF exacerbations.
Study Design And Setting:
Our study used Canadian CF registry data for 3,794 CF patients born after 1970. Data up to 2010 were analyzed, yielding 44,390 annual visit records. Our stochastic process model postulates that CF health between annual clinical visits is a superposition of chronic disease progression and an exacerbation shock stream. Death occurs when an exacerbation carries CF health across a critical threshold. The data constitute censored survival data, and hence, threshold regression was used to connect CF death to study covariates. Maximum likelihood estimates were used to determine which clinical covariates were included within the regression functions for both CF chronic health and CF exacerbations.
Results:
Lung function, Pseudomonas aeruginosa infection, CF-related diabetes, weight deficiency, pancreatic insufficiency, and the deltaF508 homozygous mutation were significantly associated with CF chronic health status. Lung function, age, gender, age at CF diagnosis, P aeruginosa infection, body mass index <18.5, number of previous hospitalizations for CF exacerbations in the preceding year, and decline in forced expiratory volume in 1 second in the preceding year were significantly associated with CF exacerbations. When combined in one summative model, the regression functions for CF chronic health and CF exacerbation risk provided a simple clinical scoring tool for assessing 1-year risk of death for an individual CF patient. Goodness-of-fit tests of the model showed very encouraging results. We confirmed predictive validity of the model by comparing actual and estimated deaths in repeated hold-out samples from the data set and showed excellent agreement between estimated and actual mortality.
Conclusion:
Our threshold regression model incorporates a composite CF chronic health status index and an exacerbation risk index to produce an accurate clinical scoring tool for prediction of 1-year survival of CF patients. Our tool can be used by clinicians to decide on optimal timing for lung transplant referral.
Related Concept Videos
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Survival Analysis
Kaplan-Meier Approach
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Statistical Methods for Analyzing Epidemiological Data
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

